A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
Public ClinicalTrials.gov record NCT00272935. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Demonstrate the Safety and Efficacy of Daily 0.3 mg Synthetic Conjugated Estrogens, A (Cenestin) for the Treatment of Vasomotor Symptoms in Postmenopausal Women
Study identification
- NCT ID
- NCT00272935
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Duramed Research
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Cenestin 0.3 mg Tablets Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Jul 2, 2012
2005 – 2007
United States locations
- U.S. sites
- 49
- U.S. states
- 20
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Huntsville | Alabama | 35801 | — |
| Duramed Investigational Site | Montgomery | Alabama | 36116 | — |
| Duramed Investigational Site | Phoenix | Arizona | 85013 | — |
| Duramed Investigational Site | Phoenix | Arizona | 85032 | — |
| Duramed Investigational Site | Tucson | Arizona | 85712 | — |
| Duramed Investigational Site | Carmichael | California | 95608 | — |
| Duramed Investigational Site | Irvine | California | 92618 | — |
| Duramed Investigational Site | San Diego | California | 72108 | — |
| Duramed Investigational Site | San Diego | California | 92103 | — |
| Duramed Investigational Site | San Diego | California | 92123 | — |
| Duramed Investigational Site | San Ramon | California | 94583 | — |
| Duramed Investigational Site | Brooksville | Florida | 34613 | — |
| Duramed Investigational Site | Coral Gables | Florida | 33134 | — |
| Duramed Investigational Site | Gainesville | Florida | 32607 | — |
| Duramed Investigational Site | Leesburg | Florida | 34748 | — |
| Duramed Investigational Site | Miami | Florida | 33143 | — |
| Duramed Investigational Site | Palm Springs | Florida | 33461 | — |
| Duramed Investigational Site | Venice | Florida | 34285 | — |
| Duramed Investigational Site | Alpharetta | Georgia | 30005 | — |
| Duramed Investigational Site | Douglasville | Georgia | 30134 | — |
| Duramed Investigational Site | Boise | Idaho | 83712 | — |
| Duramed Investigational Site | Evansville | Indiana | 47714 | — |
| Duramed Investigational Site | Lexington | Kentucky | 40509 | — |
| Duramed Investigational Site | Baltimore | Maryland | 21224 | — |
| Duramed Investigational Site | Lincoln | Nebraska | 68510 | — |
| Duramed Investigational Site | Las Vegas | Nevada | 89146 | — |
| Duramed Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Duramed Investigational Site | Cleveland | Ohio | 44122 | — |
| Duramed Investigational Site | Columbus | Ohio | 43213 | — |
| Duramed Investigational Site | Mayfield Heights | Ohio | 44124 | — |
| Duramed Investigational Site | Medford | Oregon | 97504 | — |
| Duramed Investigational Site | King of Prussia | Pennsylvania | 19406 | — |
| Duramed Investigational Site | North Wales | Pennsylvania | 19454 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Duramed Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| Duramed Investigational Site | Charleston | South Carolina | 29401 | — |
| Duramed Investigational Site | Bristol | Tennessee | 37620 | — |
| Duramed Investigational Site | Clarksville | Tennessee | 37043 | — |
| Duramed Investigational Site | Nashville | Tennessee | 37203 | — |
| Duramed Investigational Site | Dallas | Texas | 75390 | — |
| Duramed Investigational Site | Fort Worth | Texas | 76104 | — |
| Duramed Investigational Site | Houston | Texas | 77015 | — |
| Duramed Investigational Site | Houston | Texas | 77030 | — |
| Duramed Investigational Site | Houston | Texas | 77074 | — |
| Duramed Investigational Site | San Antonio | Texas | 78229 | — |
| Duramed Investigational Site | Norfolk | Virginia | 23507 | — |
| Duramed Investigational Site | Spokane | Washington | 92207 | — |
| Duramed Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00272935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2012 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00272935 live on ClinicalTrials.gov.